Ketoconazole: Clinical Trials

155 trials of Ketoconazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

116 completed, 19 terminated, 7 unknown, 4 active not recruiting. 93 Phase 1, 31 Phase 2, 14 Phase 3, 7 Early Phase 1, 7 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 193Completed 83, Terminated 7, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 231Completed 16, Terminated 11, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 314Completed 7, Terminated 3, Unknown 3, Withdrawn 1
Early Phase 17Active not recruiting 2, Completed 2, Terminated 2, Not yet recruiting 1
Not applicable7Completed 4, Unknown 2, Withdrawn 1
Phase 47Completed 5, Not yet recruiting 2

Follow Ketoconazole: new trials by email Literature Review of Ketoconazole trials Research Report on Ketoconazole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion
Ketoconazole - Mild Autonomous Cortisol Secretion
Phase 1RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)362026-07-272026-08-31
Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor.
Luliconazole Cream 1%, Topical ketoconazole 2% cream - Pityriasis Versicolor
Phase 4Not yet recruitingPAEC General Hospital, Islamabad862026-02-012026-01-12
Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor
Ketoconazole 2% Shampoo, Placebo Shampoo - Pityriasis Versicolor
Phase 4Not yet recruitingFakultas Kedokteran Universitas Indonesia762026-02-012026-03-13
Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia
Dasatinib Pill, Ketoconazole Pill - Chronic Myeloid Leukemia, Chronic Phase
Phase 2UnknownHospital Universitario Dr. Jose E. Gonzalez152024-11-012022-12-06
Azoles Targeting Recurrent High Grade Gliomas
Ketoconazole (KCZ), Posaconazole (PCZ) - Brain Tumor, Recurrent, Cancer, Advanced
Early Phase 1Not yet recruitingUniversity Health Network, Toronto302024-06-012024-03-08
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2
Ketoconazole, Luteinizing Hormone - Cryptorchidism
Not applicableUnknownAffiliated Hospital of Nantong University102024-02-032024-08-19
Administration of Repurposed Ketoconazole in Glioma Patients
Ketoconazole - Diffuse Glioma, Diffuse Glioma, Grade I
Early Phase 1Active not recruitingUniversitas Padjadjaran802023-02-282026-05-14
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
Ketoconazole - Glioblastoma, Glioblastoma Multiforme
Early Phase 1TerminatedMilton S. Hershey Medical Center12022-05-112026-01-07
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
Ketoconazole Pill (also known as nizoral), Ganirelix, Dexamethasone Pill - Sleep Restriction
Early Phase 1Active not recruitingLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center52020-02-092025-09-11
Bioavailability of Levoketoconazole and Ketoconazole Tablets
Levoketoconazole, Ketoconazole - Healthy
Phase 1CompletedCortendo AB342019-12-162020-01-31
Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Candicort®, Nizoral®, Baycuten N® - Tinea
Phase 3CompletedAche Laboratorios Farmaceuticos S.A.1252019-06-112021-09-20
ITT-5 Mechanisms of Spermatogenesis in Man
Testosterone 1% Gel, Acyline, Dutasteride - Gonadotropin Deficiency
Phase 2WithdrawnUniversity of Washington2019-06-012019-12-18
To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases
TD03, TD07, Ketoconazole 2% Shampoo - Scalp Dermatitis
Phase 3UnknownSao Thai Duong Joint Stock Company3662019-05-222022-10-26
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
Best Practice, Ketoconazole - Anatomic Stage IV Breast Cancer AJCC v8, Astrocytoma
Early Phase 1TerminatedWake Forest University Health Sciences152019-03-132026-07-31
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
Omiganan, Ketoconazole, Placebo - Seborrheic Dermatitis
Phase 2UnknownMaruho Co., Ltd.362018-10-222019-05-01
Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash
Ketoconazole, Laboratory Biomarker Analysis, Placebo Administration - Malignant Neoplasm
Early Phase 1CompletedMayo Clinic582018-09-252026-09-21
Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis
Ketoconazole, Terconazole - Vaginal Candidiasis
Phase 3UnknownAssiut University692018-04-012018-03-22
Non-inferiority Trial of Dapaconazole Versus Ketoconazole
Dapaconazole, Ketoconazole - Tinea Pedis
Phase 3CompletedBiolab Sanus Farmaceutica3602017-11-012020-07-27
Hormonal Mechanisms of Sleep Restriction - Axis Study
Ketoconazole Pill, Ganirelix, Dexamethasone - Sleep Restriction
Phase 1Active not recruitingPeter y. Liu802017-05-082025-09-11
Oral Calcitriol With Ketoconazole in CRPC
Calcitriol, Ketoconazole, Hydrocortisone - Castration-resistant Prostate Cancer
Phase 2TerminatedDonald Trump, MD12017-01-062021-02-08

Showing 20 of 155. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (23)  ·  Neoplasms (12)  ·  Dermatitis, Seborrheic (4)  ·  Lymphoma (4)  ·  Tinea Pedis (4)  ·  Hypogonadism (3)  ·  Neuroblastoma (3)  ·  Pulmonary Disease, Chronic Obstructive (3)  ·  Tinea Versicolor (3)  ·  Alzheimer Disease (2)  ·  Asthma (2)  ·  Brain Neoplasms (2)  ·  Candidiasis (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Glioblastoma (2)

Sponsors

GlaxoSmithKline (14)  ·  Boehringer Ingelheim (6)  ·  Pfizer (6)  ·  AstraZeneca (5)  ·  Abbott (4)  ·  Hoffmann-La Roche (4)  ·  Janssen Research & Development, LLC (4)  ·  Celgene (3)  ·  Eli Lilly and Company (3)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3)  ·  M.D. Anderson Cancer Center (3)  ·  National Cancer Institute (NCI) (3)  ·  Roswell Park Cancer Institute (3)  ·  South Plains Oncology Consortium (3)  ·  Astellas Pharma Inc (2)

Countries

United States (100)  ·  United Kingdom (9)  ·  Australia (5)  ·  Germany (5)  ·  South Korea (5)  ·  Brazil (4)  ·  Canada (4)  ·  Belgium (3)  ·  Netherlands (3)  ·  France (2)  ·  Singapore (2)  ·  Spain (2)  ·  China (1)  ·  Indonesia (1)  ·  Mexico (1)

Top investigators

Donald L. Trump, MD (2)  ·  Gilberto De Nucci, PhD (2)  ·  Gregory P. Swanson, MD (2)  ·  Peter Liu, MD, PhD (2)  ·  Randall E. Millikan, MD, PhD (2)  ·  Robert J Amato, DO (2)  ·  Aibing M Guo, M.D. (1)

Results publications

PMID 12560440, PMID 12610188, PMID 14747052, PMID 15020604, PMID 16258090, PMID 17404083, PMID 18073301, PMID 18270253, PMID 18401254, PMID 18445673, PMID 18451235, PMID 19029421, PMID 19734776, PMID 20430905, PMID 20881067, PMID 21480191, PMID 21642470, PMID 22174351, PMID 22393898, PMID 22463890, PMID 22510871, PMID 22534255, PMID 22606232, PMID 22845044, PMID 22895351, PMID 22932804, PMID 23150682, PMID 23303450, PMID 23377341, PMID 23533230, PMID 23715032, PMID 23750331, PMID 23754575, PMID 23851165, PMID 24009246, PMID 24298851, PMID 24323034, PMID 24417786, PMID 24655871, PMID 24824900, PMID 24918945, PMID 25047497, PMID 25100135, PMID 25211297, PMID 25514427, PMID 25667107, PMID 25807408, PMID 26381275, PMID 26872892, PMID 27171844

NIH funding

P30CA016672 (3), 2009 (2), 2008 (1), N01HR56165 (1), N01HR56166 (1), N01HR56167 (1), N01HR56168 (1), N01HR56169 (1), N01HR56170 (1), N01HR56171 (1), N01HR56172 (1), N01HR56173 (1), N01HR56174 (1), N01HR56175 (1), N01HR56176 (1)